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Summary 
Tyrosine phosphorylation of the  Cbl protooncogene has been shown to occur after engage- 
ment of a number of different receptors on hematopoietic cells.  However, the mechanisms by 
which  these  receptors induce  Cbl tyrosine phosphorylation are poorly understood.  Here we 
demonstrate that engagement of the high affinity IgE receptor (FceR1)  leads to the  tyrosine 
phosphorylation of Cbl and  analyze how this  occurs.  We show that  at least part  of FcetLI- 
induced Cbl tyrosine phosphorylation is mediated by the Syk tyrosine kinase, and that the Syk- 
dependent tyrosine phosphorylation of Cbl occurs mainly distal to the Cbl proline-rich region 
within the COOH-terminal 250  amino acids.  Furthermore, we show by coprecipitation that 
Cbl is present in a complex with Syk before receptor engagement, that the proline-rich region 
of Cbl and a region of Syk comprised of the two SH2 domains and intradomain linker are re- 
quired for formation of the complex, and that little or no tyrosine-phosphorylated Cbl is de- 
tected in complex with Syk. Overexpression of truncation mutants of Cbl capable of binding 
Syk has the effect of blocking tyrosine phosphorylation of endogenous Cbl. These results de- 
fine  a  potentially  important  intramolecular  interaction  in  mast  cells  and  suggest  a  complex 
function for Cbl in intracellular signaling pathways. 
T 
he Ag and Ig receptors on hematopoietic cells, includ- 
ing the T  cell and B  cell antigen receptors and the re- 
ceptors for the Fc components oflgE and IgG, share multi- 
ple  structural  and  functional  features  (1-4).  All  consist  of 
multiple  subunits,  with  the  extracellular  ligand-binding 
components distinct  from the  signal-transducing  subunits. 
The signaling subunits of these receptors are all thought to 
transduce  signals  primarily  through  tyrosine phosphoryla- 
tion-mediated  signaling  pathways.  Nonreceptor  tyrosine 
kinases  are  coupled  to  the  signaling  subunits  of receptors 
through one or more specialized motifs found in their cy- 
toplasmic sequences,  the  immune  receptor tyrosine-based 
activation motif (ITAMs) 1 (5, 6).  ITAMs contain two pre- 
cisely spaced tyrosines that are subject to phosphorylation 
by Src family kinases,  resulting in  the  creation of binding 
sites  for other tyrosine kinases and signaling molecules.  A 
model  that  describes  the  initial  events  after receptor  en- 
1Abbreviations used in this paper: EMEM, Eagle's MEM; hemagglutinin; 
HSA, human serum albumin; ITAM, immune receptor tyrosine-based 
activation motif; PTK, protein tyrosine kinase. 
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gagement  has  been  proposed.  The  relevant  Src  kinase  is 
rapidly activated by receptor aggregation induced by ligand 
or cross-linking antibody (2, 7, 8).  ITAMs are rapidly tyro- 
sine phosphorylated by the Src kinase. The Syk or ZAP-70 
protein tyrosine kinase (PTK), depending on the cell type, 
binds to the doubly phosphorylated ITAM via tandem SH2 
domains. This binding event in itself has been shown to ac- 
tivate the Syk kinase in vitro (9,  10).  When bound to the 
receptor ITAMs, Syk or ZAP-70 can be tyrosine phosphor- 
ylated by the  activated  Src  kinases.  This  phosphorylation 
mediates ZAP-70 and Syk activation (11,  12).  Members of 
the Btk family of PTK are also regulated by receptor liga- 
tion in these systems, and have been shown to be activated 
by a  Src  kinase  (13,  14).  Activation  of these  various  ty- 
rosine kinases then leads to signal propagation via tyrosine 
phosphorylation of various downstream substrates. 
Cbl, the product of the protooncogene c-Cbl, is a prom- 
inent  tyrosine kinase substrate detected in these and other 
tyrosine  kinase-mediated  signaling  systems  (15-24).  Cbl 
was first described as the cellular homologue of the trans- 
forming gene  of the  Cas-NS1  retrovirus,  a  murine  virus 
capable  of causing  pre-B  cell  lymphomas  and  fibroblast 
transformation  (25,  26).  Examination  of the  Cbl primary 
structure reveals several apparent modular domains, includ- 
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(residues  1-357),  a proline-rich  region  (residues 481-688), 
a  leucine  zipper  motif  (residues  855-COOH  terminus), 
and multiple  potential  SH2  binding  motifs.  The  Cbl  pro- 
line-rich  region  is  particularly  notable  for  containing  sev- 
eral consensus SH3 binding motifs. 
Of great  importance  is  that  the  Cbl  molecule  has  been 
found to bind to a number of molecules known to be criti- 
cal  in  signal  transduction.  These  include  tyrosine  kinases 
such as Fyn, ZAP-70,  and Btk,  the adapter molecules Grb2, 
Crk, and Nck, and the lipid/protein kinase PI3 kinase (15- 
18,  27-34).  In  addition,  the  product  of the  Caenorhabditus 
elegans  SLI-1  gene,  a  homologue  of Cbl,  has  been  postu- 
lated to be a negative regulator of the Ras pathway based on 
genetic data (35). Despite these observations,  the molecular 
function  of Cbl  and tyrosine-phosphorylated  Cbl during ty- 
rosine phosphorylation-mediated  signaling remains unclear. 
To  date  one  critical  receptor  found  on  specialized  he- 
matopoietic  cells  has  not yet been  reported  to  induce  the 
tyrosine  phosphorylation  of  Cbl  after  activation.  This  is 
FceRI,  which  is  found  on  mast  cells  and basophils,  and is 
responsible for binding IgE  (3,  36,  37).  FceI<I consists  of a 
ligand-binding ot chain,  and two  ITAM-containing  signal- 
ing chains,  [3  and  y,  the  latter  of which  forms  a  disulfide- 
linked  homodimer.  Extensive  analysis  reveals  that  the  Src 
kinase Lyn is bound to the  [3 chain,  is activated by receptor 
aggregation  and phosphorylates  the  y  chain.  Phosphoryla- 
tion of the y  chain ITAM enables Syk to bind and become 
tyrosine phosphorylated  and activated.  Tyrosine phosphor- 
ylation of multipie substrates  ensues. The generation of re- 
combinant  vaccinia  constructs  encoding  various  cytoplas- 
mic  signaling  components  has  simplified  the  analysis  of 
tyrosine kinase signaling in this system (38). We report here 
that FcdKI  engagement induces  Cbl tyrosine phosphoryla- 
tion  in  RBL  cells.  Using  relevant  recombinant  vaccinia 
constructs,  we identify the PTKs capable  of this phosphor- 
ylation, perform preliminary mapping of the tyrosine phos- 
phorylation of Cbl,  and demonstrate a complex of Cbl and 
the PTK Syk. We observe that the fraction of Cbl found in 
complex with Syk after Fc~RI triggering is far less tyrosine 
phosphorylated  than  total  Cbl.  These  results  implicate  Cbl 
as  an  important  participant  in  signaling  events  coupled  to 
the FcelLI. 
Materials  and Methods 
Cell Lines and Cell Culture.  The rat mast cell line, RBL-2H3, was 
cultured in Eagle's MEM/16% FCS. The mouse fibroblast cell line, 
3T3E, which stably expresses FceRI ix, [3, and y chains was cultured 
in Dulbecco's MEM/10%  FCS supplemented with 300  ixg/ml of 
hygromycin B  (Calbiochem  Novabiochem,  San  Diego,  CA)  and 
500 ~g/ml of G418 (Life Technologies, Gaithersburg,  MD). 
Antibodies.  Rabbit polyclonal anti-cbl antibody C15 was pur- 
chased from Santa  Cruz Biotechnology,  inc.  (Santa  Cruz,  CA). 
Rabbit polyclonal anti-cbl antibodies, IK2 and R5  (15), were re- 
ported previously.  IK5 antibody recognizes v-cbl  (1-357  human 
c-cbl).  Rabbit  polyclonal  anti-syk  antibody  which  recognizes 
both rat and porcine syk was purchased from Upstate Biotechnol- 
ogy, Inc.  (Lake Placid,  NY).  Rabbit polyclonal anti-porcine  syk 
antibody  and  rabbit  polyclonal  anti-mouse  lyn  were  reported 
previously (38). Anti-HA antibody, 12CA5 (mouse monoclonal), 
was  purchased  from Boehringer Mannheim  Corp.  (Indianapolis, 
IN). Rabbit polyclonal anti-GST antibody, used as a control anti- 
body was a gift of Dr. S. Desiderio (Johns Hopkins University). 
cDNAs and Recombinant Vaccinia Virus.  The  cDNA  constructs 
1-906  human  hemagglutinin  (HA)  c-cbl  (wild  type)  and  1-480 
human  HA  c-cbl  were  reported  previously  (39).  1-655  human 
HA c-cbl was generated from pUC HUT cbl (39).  1-840 human 
HA  c-cbl  was  generated  by  ligating  synthetic  oligonucleotides 
(5'-CTGTTAGAAGCTTTCTAGAGGTAC-3'  and  3'-GAC- 
AATCTTCGAAAGATCTC-5')  at unique  PvulI  site  in  1-906 
human HA c-cbl. All of the HA tag were added at the amino ter- 
minus,  cDNAs  for porcine  Syk  (40),  porcine  Syk-T  (41),  and 
murine Lyn (42) were reported previously, cDNA for kinase in- 
active Lyn was reported previously (13).  The  cDNAs were sub- 
cloned into the pSC-65 vaccinia recombination plasmid. Recom- 
binant  viruses  were  selected with  5-bromo-2-deoxyuridine  and 
beta galactosidase, amplified and titered as previously described (38). 
Vaccinia Infection, Cell  Harvest, Cell  Stimulation,  and  Cell  Ly- 
sis.  Two protocols were used for infecting and lysing RBL-2H3 
cells. In  one,  used for experiments  shown in  Figs. 2,  3,  and  12 
cells were infected in 5% FCS for "-'15 h in the presence of 1 Ixg/ 
ml monoclonal anti-DNP for receptor loading.  Infected cells were 
harvested with  PBS  with  1 mM  EDTA,  washed with  EMEM, 
and  resuspended  in  EMEM.  Cells  were  stimulated  by  adding 
DNP-human  serum  albumin  (HSA)  (Sigma  Chemical  Co.,  St. 
Louis, MO)  to a final  concentration  of 200  ng/ml for the indi- 
cated  time.  Cells  were  lysed  in  0.5%  Triton  X-100,  150  mM 
NaC1, 200 mM boric acid, pH 8.0, 5 mM EDTA, 5 mM sodium 
fluoride,  1 mM  sodium orthovanadate,  10  p.g/ml  aprotinin,  10 
la,  g/ml leupeptin, and 10 b~g/ml pepstatin. For all other R_BE ex- 
periments,  cells were infected with  5 PFU/cell  of the indicated 
virus in EMEM with 5% FCS for 2 h, washed once with EMEM, 
and incubated for 8-10  h  in EMEM/5%  FCS with  1 b~g/mI of 
monoclonal anti-DNP for surface  IgE receptor loading.  Infected 
cells were harvested with PBS with  1 mM EDTA,  washed with 
EMEM,  and  resuspended  in  EMEM.  Cells  were  stimulated  by 
adding DNP-HSA (Sigma Chemical Co.) to a final concentration 
of 200 ng/ml for the indicated time.  Cells were lysed in 1% Brij 
96 lysis buffer containing  150 mM NaC1, 50 mM Tris, pH 7.5, 
5  mM EDTA,  1 mM sodium vanadate,  10 ~g/ml aprotinin,  10 
~g/mI Ieupeptin, and 250 ng/ml p-nitrophenyl p'-guanidinoben- 
zoate.  3T3E  cells were plated  in  DMEM/10%  calf serum  with 
anti-DNP and cultured overnight.  The next morning cells were 
infected with 5 PFU/cell in serum-free DMEM and anti-DNP (1-5 
I,  zg/ml)  again.  The infection  was allowed to  progress for 2-4 h, 
with harvest and stimulation as above except 400 ng/DNP-HSA 
for stimulation for 4 min. Cells were lysed as described in the first 
R_BL cell protocol. 
Immunoprecipitation, Electrophoresis, and Western Blotting.  Proteins 
in detergent lysates were immunoprecipitated,  washed, and eluted 
by boiling in SDS sample buffer as previously described (43). Pro- 
teins  were  separated  by  SDS-PAGE,  transferred  to  membranes, 
and  detected  by  immunoblotting  and  enhanced  chemilumines- 
cence (Amersham Corp., Arlington Heights, IL). 
Results 
Cbl  Is  Tyrosine  Phosphorflated  qfier  FcERI  Engagement. 
RBL-2H3  cells were used to determine whether Cbl would 
become tyrosine phosphorylated in response to FcelLI liga- 
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Figure 1.  Antigenic  stimulation via the FcERI leads to Cbl tyrosine 
phosphorylation, tLBL-2H3 cells were incubated for 15 h in the presence 
of monoclonal IgE anti-DNP. Cells were triggered or not for the indi- 
cated time with DNP-HSA and lysed. Postnuclear  supernatants  were sub- 
jected to SDS-PAGE, transfer, and immunoblotting with antiphosphoty- 
rosine antibodies (top) or anti-Cbl antibodies (bottom). The prominant 
50-kD band in the upper panel is lg heavy chain. 
anti-Cbl blot 
ant,-L,n b,ot 
Figure 2.  Overexpression  of Lyn or an inactive form of Lyn in RBL- 
2H3 cells. RBL-2H3 cells were infected with vaccinia  vector, with Lyn 
recombinant virus, or with a recombinant virus made with a kinase-dead 
form of Lyn. Cells were incubated with  monoclonal IgE  anti-DNP. 
FceRl was aggregated (+)  or not (-) with DNP-HSA. Cellular lysates 
were subjected to immunoprecipitation  with anti-Lyn antibodies, SDS- 
PAGE, and immunoblotting  with antiphosphotyrosine  antibodies  (top) or 
anti-Cbl antibodies (middle). For the lower panel, cellular lysates were 
subjected to SDS-PAGE and blotted with anti-Lyn antibodies. 
tion.  Cells were incubated overnight at 37  °  with an anti- 
DNP  IgE  rnAb, then washed,  and incubated for varying 
lengths of time with DNP-HSA as indicated (Fig.  1).  Cbl 
was  immunoprecipitated from detergent lysates with  spe- 
cific polyclonal antibodies. Immunoblotting  of the electro- 
phoresed and transferred proteins was performed with an- 
tiphosphotyrosine mAbs. No  tyrosine-phosphorylated Cbl 
was detected in the absence of stimulation, but a prominent 
tyrosine-phosphorylated protein of 120-kD  apparent mo- 
lecular mass was detected after 2 and 5 min of stimulation. 
A  decrease in signal was noted after 10 rain of stimulation. 
The same membrane was stripped and subjected to reblot- 
ting with  anti-Cbl antibodies indicating that  the  level of 
Cbl protein was  identical in all lanes.  Additional experi- 
ments  (not shown)  demonstrated that  Cbl tyrosine phos- 
phorylation in RBL cells could be detected as  early as  30 
seconds  after  FceRI  ligation.  These  studies  establish  that 
activation of the  FcetLI  induces tyrosine phosphorylation 
of Cbl in a fashion analogous to that seen with other anti- 
gen and Ig receptors. 
Both  Lyn  and  Syk  Enhance  FcERI-mediated  Cbl  Tyrosine 
Phosphorylation.  As  a  first  step  in analyzing how  FceRI- 
mediated  Cbl  tyrosine phosphorylation occurs,  we  over- 
expressed  the  Lyn and Syk  tyrosine kinases to  determine 
whether either of these protein tyrosine kinases might be 
responsible for  tyrosine phosphorylation of Cbl  in RBL- 
2H3 cells. Activation of the Lyn tyrosine kinase is thought 
to  be  one of the  earliest events to  occur after FcERI  en- 
gagement  due  to  its  involvement in  phosphorylation  of 
FceP,.I  ITAMs. Therefore,  we first investigated the effects 
of Lyn  overexpression  on  Cbl  tyrosine  phosphorylation. 
The Lyn PTK was overexpressed in RBL-2H3 cells by in- 
fection with a Lyn vaccinia recombinant virus. In parallel, 
cells were infected with viral vectors expressing no kinase 
or a kinase-inactive form of Lyn. Expression of active and 
inactive Lyn was  detected  by immunoblotting with  anti- 
Lyn antibodies (Fig.  2,  bottom).  The  cells were  incubated 
with anti-IgE and then with or without DNP-HSA for ac- 
tivation.  FceR.I-induced Cbl  tyrosine  phosphorylation is 
not  affected  by  the  vaccinia infection (data  not  shown). 
Overexpression of an inactive form of Lyn did not affect 
Cbl tyrosine phosphorylation relative to the control virus, 
which  expressed  no protein. However,  overexpression of 
wild-type Lyn resulted in an increase in the basal level of 
Cbl tyrosine phosphorylation and a marked increase in the 
level of tyrosine phosphorylation observed after Fcd~I en- 
gagement. This result indicates that tyrosine phosphoryla- 
tion of Cbl can be regulated by the Lyn PTK. However, 
because of the proximal position of Lyn in Fc~RI signaling 
pathways,  one  can  not  determine  from  this  experiment 
whether  this  is  a  direct  or  indirect effect.  Syk  activation 
closely follows and is dependent on activation of the Lyn 
PTK in this system (36). To test the possible role of Syk in 
Cbl phosphorylation in RBL-2H3 cells, vaccinia recombi- 
nants were used to overexpress Syk or a truncated form of 
Syk which lacks enzymatic activity (Syk-T) (Fig. 3). Syk-T 
overexpressed 
proteins:  Syk  Syk(T) 
Ag stimulation:  I-  +  II  -  +  II  -  ÷1 
Cbl--  anti-PY blot 
anti-Cbl blot 
Figure 3.  Overexpression  of Syk or a truncated form of Syk in P,.BL- 
2H3 cells. P,.BL-2H3 cells were infected with vaccinia  vector, with Syk 
recombinant virus, or with a recombinant virus made with a truncated 
form of Syk. Cells were incubated with  monoclonal IgE  anti-DNP. 
Fcd:kl was aggregated (+)  or not (-) with DNP-HSA. Cellular lysates 
were subjected to  immunoprecipitation with  anti-Cbl antibodies and 
SDS-PAGE, and were immunoblotted with antiphosphotyrosine  anti- 
bodies (top) or anti-Cbl (bottom). 
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Figure 4.  Overexpression of Cbl with and without Lyn and Syk or a 
truncated form of Syk in 3T3 cells. Cells were infected with recombinant 
Cbl virus, with both Cbl and Lyn recombinants, with both Cbl and Syk 
recombinants, or with Cbl, Lyn, and Syk recombinants. Cells  were incu- 
bated with monoclonal IgE anti-DNP.  Fcel<I was aggregated (+) or not 
(-) with DNP-HSA.  Cellular lysates  were subjected to immunoprecipi- 
tation with anti-Cbl antibodies and SDS-PAGE, and were immunoblot- 
ted with antiphosphotyrosine antibodies (top) or anti-Cbl (bottom). 
had no effect on the level of basal or receptor-induced ty- 
rosine phosphorylation of Cbl relative to infection with the 
control virus.  However,  overexpression of wild-type Syk 
resulted  in  a  severalfold increase  in  the  level of tyrosine- 
phosphorylated Cbl detected after FceRI ligation. Levels of 
Syk  and  truncated  Syk  were  comparable  (not  shown). 
Therefore,  Syk also lies in the pathway leading to  Cbl ty- 
rosine phosphorylation. 
Activation of Syk  Can Reconstitute  Cbl  Tyrosine  Phosphory- 
lation in a Nonhematopoietic  Cell Line.  Taken  together,  the 
above  results  are  consistent  with  a  mechanism  for  Cbl 
phosphorylation in which Syk directly phosphorylates Cbl, 
with  the  effect  of Lyn being mediated indirectly through 
enhanced  activation  of  Syk.  However,  P,.BL-2H3  cells 
contain  other  hematopoietic-specific tyrosine  kinases  and 
signaling molecules, which confound the drawing of defin- 
itive  conclusions  from  the  above  experiments.  To  deter- 
mine  whether  Syk was  capable of directly tyrosine phos- 
phorylating Cbl, a previously described reconstitution system 
was used (38, 44). In this system, NIH 3T3 cells have been 
stably transfected with the three FceR.I components  (3T3E 
cells). Since NIH-3T3  cells lack all known  hematopoietic 
specific tyrosine kinases, only very weak FceRI phosphory- 
lation occurs in the absence of exogenous kinase expression 
in 3T3E  cells. When  the Lyn kinase is expressed in them, 
FceRI  clustering leads to  a  normal  level  of phosphoryla- 
tion. In addition, Syk expression alone allows weak but de- 
tectable activation of Syk via the receptor, while expression 
of both Lyn and Syk results in robust Syk activation similar 
to  that found  in  RBL-2H3  cells. These  events  have  now 
been shown to almost exactly reproduce those which occur 
in  natural  FceP,.I signaling systems  (44).  To  analyze  how 
Lyn and Syk were contributing to Cbl tyrosine phosphory- 
lation,  3T3E  cells were  infected with  a  recombinant vac- 
cinia-Cbl virus alone, or with Cbl plus one, or both of the 
PTKs  (Fig. 4).  A  basal level of Cbl tyrosine phosphoryla- 
tion was detected in the presence of the endogenous PTKs 
in these cells. There was no increase in tyrosine phosphory- 
lation detected after receptor ligation in the absence of ei- 
ther Lyn or Syk. Infection with Lyn resulted in no increase 
in the basal or stimulated level of Cbl tyrosine phosphory- 
lation.  However,  expression  of Syk followed by receptor 
ligation led to a marked increase in Cbl tyrosine phosphor- 
ylation. The  addition of Lyn with  Syk did not  result in  a 
greater  level  of tyrosine  phosphorylation  than  when  Syk 
alone was expressed with Cbl. These results indicate that in 
the absence of the Syk PTK,  Cbl is not tyrosine phosphor- 
ylated by FceP,.I ligation. In addition, since other hemato- 
poietic-specific tyrosine kinases,  such  as  those  of the  Btk 
family, are absent, these data strongly suggest that activated 
Syk is able to directly tyrosine phosphorylate Cbl. 
Syk-dependent  Cbl Tyrosine Phosphorylation  Occurs Distal to 
the Cbl Proline-Rich Region.  The  next series of experiments 
was  undertaken  to  further  explore the  function  of Syk in 
the tyrosine phosphorylation of Cbl in RBL-2H3 cells. We 
first endeavored to set up experimental conditions in which 
Syk-dependent phosphorylation of Cbl could be readily as- 
sayed.  Therefore,  we  analyzed Cbl  tyrosine phosphoryla- 
tion induced in R.BL-2H3  cells after overexpression of Cbl 
and Syk or truncated Syk (Fig. 5). As was seen in the earlier 
experiments where Cbl was not overexpressed, there was a 
rapid and marked increase in the  tyrosine phosphorylation 
of Cbl  dependent  on  overexpression  of full-length  Syk. 
Tyrosine phosphorylation detected by immunoblotting was 
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Figure 5.  Time course ofCbl ty- 
rosine phosphorylation in RBL-2H3 
cells  overexpressing  Cbl  alone  or 
with  active  and  inactive  forms of 
Syk. IR,  BL-2H3  cells were  infected 
with  recombinant  Cbl  virus  plus 
vector  or with  either  wild-type  or 
truncated  Syk  recombinant  virus. 
Cells were  incubated  with  mono- 
ctonal IgE anti-DNP.  FceP,.I  was ag- 
gregated for the indicated amount of 
time  with  DNP-HSA.  Cellular ly- 
sates were subjected to immunopre- 
cipitation  with  anti-Cbl  antibodies 
and SDS-PAGE, and were immuno- 
blotted  with  antiphosphotyrosine 
antibodies (top) or anti-Cbl (bottom). 
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Figure 6.  Truncation mapping of Cbl tyrosine 
phosphorylation after Syk overexpression, tLBL- 
2H3 cells were infected with recombinant Syk vi- 
rns plus vector  or with  truncated  or wild-type 
Cbl  recombinant  virus. Cells  were  incubated 
with rnonoclonal lgE anti-DNP.  FceRI was ag- 
gregated (+) or not (-) with DNP-HSA. Cellu- 
lar lysates  were subjected to immunoprecipitation 
with  rnonoclonal anti-HA antibodies. Irnrnuno- 
precipitates were  resolved on  SDS-PAGE  and 
irnmunoblotted  with  antiphosphotyrosine  anti- 
bodies (top) or R.5 anti-Cbl (bottom). 
maximal by 1 min of stimulation. A  gradual decrease in ty- 
rosine-phosphorylated Cbl was detected over 10 min. There 
was no increase in phosphorylation with overexpression of 
the truncated (inactive) form of Syk. The overexpression of 
Syk in these conditions makes Syk the most prominent ty- 
rosine phosphoprotein  detectable in  cell lysates  (Scharen- 
berg,  A.M.,  and J.-P.  Kinet,  unpublished  data),  and  these 
experimental  conditions  therefore  provide  a  system  in 
which  Cbl  tyrosine phosphorylation is  dependent  on  Syk 
rather than other tyrosine kinases. 
To map the site of Cbl tyrosine phosphorylation, a series 
of truncation mutations of Cbl were constructed with HA 
epitope  tags  at  the  NH 2  terminus.  These  were  then  ex- 
pressed  as  vaccinia recombinants  for  expression  in  RBL- 
2H3  cells. Truncation  of the COOH  terminus of the full- 
length  906  amino  acid  protein  to  create  an  840  residue 
truncated  protein  removes  a  leucine-rich region.  Genera- 
tion  of a  655  amino  acid construct  removes  an  acidic re- 
gion.  Cbl 1-480 lacks a  proline-rich region, which is pos- 
tulated  to  be  involved  in  protein-protein  interactions 
mediated by SH3-containing proteins. All constructs were 
expressed and immunoprecipitated using anti-HA antibod- 
ies.  Immunoblotting  with  anti-Cbl antibodies, which  de- 
tect the different truncated forms of Cbl,  revealed compa- 
rable levels of protein (Fig. 6).  Syk was expressed alone or 
with  the  different  Cbl  constructs.  Tyrosine  phosphoryla- 
tion  of overexpressed,  full-length  Cbl  is  clearly detected. 
Similarly, tyrosine phosphorylation of Cbl 1-840 is present 
after Fcel~I ligation. This truncation results in a loss of two 
tyrosine residues.  Further truncation  of Cbl to  655  amino 
acids  results  in  marked,  if not  complete,  loss  of tyrosine 
phosphorylation.  Five  additional  tyrosine  residues  are  re- 
moved in this deletion. We detect no tyrosine phosphory- 
lation of the NH2-terminal 480 residues of Cbl. The results 
suggest  that  the  predominant  sites  of Syk-dependent  ty- 
rosine  phosphorylation  are  in  the  COOH-terminal  250 
amino acids. 
Syk Exists in a Complex with  Cbl in Both  Unstimulated and 
Stimulated  Cells.  The ability of Syk to tyrosine phosphor- 
ylate Cbl even in nonhematopoietic cells strongly suggests 
that Cbl and Syk might interact directly. In addition, as dis- 
cussed above,  there  is ample precedent for interactions of 
Cbl with critical signaling proteins. We thus asked whether 
a  complex of Cbl and Syk could be demonstrated. To  ad- 
dress  such  a  possibility, activated and  nonactivated  RBL- 
2H3 cells were lysed and subjected to immunoprecipitation 
with antibodies directed at Cbl and Syk, and, as a  control, 
with  irrelevant  antibodies  (Fig.  7).  Immunoblotting  with 
anti-Cbl  and  control  antibodies  confirmed  that  the  anti- 
Cbl  immunoprecipitations  were  specific.  More  impor- 
tantly, precipitation with  anti-Syk antibodies followed by 
probing  with  anti-Cbl  reagents  revealed  that  a  Cbl-Syk 
Ag stimulation:  -I-  -I-  -  4- 
200-- 
97-- 
69"- 
anti-pY  blot 
antbCbl  blot 
I  I  I  I 
Figure 7.  A Cbl-Syk complex is found without  protein  overexpres- 
sion. RBL-2H3  cells were incubated for 15 h in the presence of rnono- 
donal IgE anti-DNP.  Cells were triggered or not for the indicated time 
with  DNP-HSA and lysed. Postnuclear supematants were subjected to 
immunoprecipitation  with  control  antibodies or antibodies directed at 
Syk or Cbl. Eluted protein was subjected to SDS-PAGE, transfer, and im- 
munoblotting with antiphosphotyrosine antibodies (top) or anti-Cbl anti- 
bodies (bottom). 
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Figure  8.  Identification of a Cbl-Syk complex. RBL- 
2H3 cells were infected with recombinant Syk virus plus 
vector or with both  recombinant Syk and Cbl viruses. 
Cells were incubated with  monoclonal IgE  anti-DNP. 
Fc~RI was aggregated (+)  or not (-) with DNP-HSA. 
Cellular lysates were subjected to irumunoprecipitation 
with  the  antibodies directed against either Syk or Cbl. 
Proteins were electrophoresed and iruruunoblotted with 
anti-Cbl antibodies. The film shown in this experiment 
was exposed for 5 s. 
complex could be found. No differences in the amount of 
this complex could be detected after activation of the ceils 
via the FceRI. 
To further analyze and map the Cbl-Syk interaction, co- 
precipitation  conditions after  overexpression  of Syk  and 
Cbl were defined in RBL-2H3 cells (Fig. 8). Syk was over- 
expressed with or without Chl. Without overexpression of 
Cbl, the brief exposure of the film (5 s) was insufficient to 
demonstrate endogenous Cbl with anti-Cbl antibodies, or 
the  complex of Syk with endogenous Cbl using anti-Syk 
antibodies. Cbl and the Cbl-Syk complex were detected in 
longer exposures.  The  overexpression of Cbl was  clearly 
demonstrated by anti-Cbl immunoprecipitation and immu- 
noblotting. Antibodies to Syk coprecipitated a large amount 
of the overexpressed Cbl protein, No Cbl was detected when 
irrelevant antibodies were used in control immunoprecipi- 
tations. There was no change in the amount of Cbl copre- 
cipitation after activation of the cells.  Therefore, these con- 
ditions accurately represent the Cbl/Syk interaction found 
in the absence of overexpression. 
The  Cbl truncation mutants were  then used  to  define 
the  portion  of the  molecule involved in  the  interaction 
with Syk.  Syk was overexpressed with the full-length and 
truncated forms  of Cbl  (Fig.  9).  A  complex  of Syk with 
full-length Cbl was detected.  Truncations of Cbl contain- 
Overexpression- 
Syk+ focrn  of Cbl : 
2OO-- 
97-- 
69-- 
46-- 
anti.$yk  Ip 
anti-Cbl  blot 
ing amino acids 1-840 or 1-655 also bound to Syk. How- 
ever, expression of a Cbl truncation generated by removal 
of the  proline-rich domain  (Cbl  1-480)  failed  to  form  a 
complex  with  Syk.  Additional experiments  (not  shown) 
confirmed that the  Cbl  1-480 truncation can be detected 
above the heavy chain band of immunoglobulin. Another 
experiment was  performed  to  test  whether  truncation of 
Syk abrogates interaction with Cbl (Fig. 10).  Anti-Syk im- 
munoprecipitates  were  subjected  to  electrophoresis  and 
immunoblotting  with anti-Cbl antibodies. This experiment 
revealed that both full-length and truncated Syk binds to 
the  Cbl  protein.  A  similar experiment demonstrates  that 
the truncated Syk protein binds truncated Cbl (1-655) (not 
shown). 
Cbl Found in Complex with Syk in Activated Cells Demon- 
strates Diminished Tyrosine Phosphorylation.  During the co-pre- 
cipitation experiments, it was noted that tyrosine-phosphory- 
lated Cbl was rarely detected in anti-Syk immunoprecipitates. 
This is demonstrated in an overexpression study in which 
RBL-2H3 cells were infected with both Cbl and Syk and 
activated or not via FceRI  (Fig.  11).  The cells were  then 
lysed, and antibodies to Syk and Cbl, as well as control an- 
tibodies, were used for immunoprecipitation. Control im- 
munoprecipitations demonstrated that the Cbl coprecipita- 
tion with Syk is specific. A tyrosine-phosphorylated protein 
likely to be Syk appears to coprecipitate with Cbl (last lane). 
Of note is that the Cbl directly precipitated from lysates of 
activated cells is  heavily tyrosine phosphorylated.  In con- 
trast, the Cbl that coprecipitates with Syk from these same 
OvW 
protein:  Syk  Syk + Cbl  Syk(T)  + Cbl 
I 11  It  I 
Ag stimulation:  ,4-  4-  4- 
anti.Syk ip 
anS-Cbl blot 
Figure 9.  Syk binds truncated Cbl. RBL-2H3 cells were infected  with 
recombinant  Syk virus plus vector or with truncated or wild-type Cbl re- 
combinant virus. Cellular lysates were subjected to iruruunoprecipitation 
with antibodies  directed against Syk. Proteins were electrophoresed and 
irumunoblotted with R5 anti-Cbl antibodies. The film  was exposed for 
5 s. In a 2-ruin exposure, the association between Syk and endogenous 
Cbl was detected in cells without Cbl overexpression. 
Figure  10.  Cbl binds truncated Syk. RBL-2H3 cells were infected 
with recombinant Syk virus plus vector, recombinant Syk and Cbl re- 
combinant  viruses, or with truncated Syk and Cbl viruses. Cellular  lysates 
were  subjected to  immunoprecipitation with the  antibodies directed 
against Syk. Proteins  were electrophoresed and irumunoblotted  with anti- 
Cbl antibodies. Exposure of the film  was for 1 ruin. A 5-s exposure was 
not sutticient  to detect endogenous  Cbl in lane  2. 
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Figure 11.  Cbl  in complex with Syk  is not tyrosine phosphorylated. 
RBL-2H3  cells  were  infected  with  recombinant  Syk  and  Cbl  viruses. 
Cells were incubated with monodonal IgE anti-DNP. FceRI was aggre- 
gated  (+) or not (-) with DNP-HSA. Cellular lysates were subjected to 
immunoprecipitation  with  control  antibodies  or  antibodies  directed 
against  either Syk or Cbl.  Proteins were electrophoresed and immuno- 
blotted with antiphosphotyrosine (top)  or anti-Cbl (bottom)  antibodies. 
lysates  contains  markedly less  tyrosine  phosphate.  This  is 
despite  the  presence  of comparable levels of Cbl in  these 
two precipitates as detected by anti-Cbl blotting. 
Overexpression of Cbl Truncation Mutants  Capable of Bind- 
ing Syk Results in Inhibition of Endogenous Cbl Tyrosine Phos- 
phorylation.  The  absence  of tyrosine-phosphorylated Cbl 
within  the  Cbl-Syk complex suggested that  a  function  of 
this complex might be to regulate Cbl tyrosine phosphory- 
lation.  The  ability  to  selectively  isolate  endogenous  Cbl 
protein away from the  overexpressed form of the  protein 
enabled us to  test the  effect of Cbl overexpression on the 
endogenous form of the protein. Specifically, we could ask 
whether  overexpression of Cbl led  to  changes in  tyrosine 
phosphorylation  of endogenous  Cbl.  In  this  experiment 
(Fig.  12) RBL-2H3 cells were separately infected with vec- 
tor or with recombinant vaccinia encoding either of three 
truncation  mutants  of Cbl,  1-480,  1-655,  or  1-840.  The 
three  forms  were  well  expressed  as  detected  by  blotting 
with antibodies to the NH2-terminal HA tag (bottom). En- 
dogenous  Cbl  was  detected  by immunoprecipitation  and 
immunoblotting  with  an  antibody  directed  against  the 
COOH-terminal 15 amino acids of the protein and there- 
fore  not  found  in  the  three  truncation  mutants  (middle). 
Stimulation of the cells by cross-linking the FcetkI receptor 
leads to an increase in tyrosine phosphorylation of endoge- 
nous  Cbl in  cells  infected with vector alone.  Overexpres- 
sion of the  1-480  Cbl truncation  mutant had no effect on 
the  tyrosine phosphorylation  of endogenous  Cbl  induced 
by receptor ligation.  However, there was a marked inhibi- 
tion  of this  tyrosine phosphorylation with  overexpression 
of the  1-655  or  1-840  mutants.  Note  that  these  are  two 
truncation  mutants  shown  earlier  (Fig.  9)  to  bind to  Syk. 
Thus overexpression of Cbl truncation mutants that are ca- 
pable of binding Syk has the  functional  effect of blocking 
tyrosine phospborylation of endogenous Cbl. 
Discussion 
It has been previously established that the Cbl protein is 
a prominent tyrosine kinase substrate in a number of signal- 
ing pathways,  including  those  of several antigen  receptors 
and a variety of growth factor and cytokine receptors (15- 
24,  29).  The  apparent  ubiquitous  nature  of Cbl  involve- 
ment in tyrosine kinase signaling pathways suggests  that Cbl 
plays a general and critical role in tyrosine kinase-mediated 
signal  transduction.  However,  at present there  is  no  clear 
function which can be attributed to Cbl or tyrosine-phos- 
phorylated  Cbl.  Understanding  how  Cbl  tyrosine  phos- 
phorylation is generated is  a  necessary first  step in  under- 
Overexpressed form of Cbl:  none 
Ag stimulation:  --  4- 
1-480  1-655  1-840 
--  +  -  4-  -  + 
antl-Cbl Ip  anti-PY blot 
antI-Cbl Ip 
lysate 
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Figure  12.  Overexpression  of  truncation 
mutants of Cbl  inhibits  tyrosine phosphoryla- 
tion of endogenous Cbl.  RBL-2H3  cells were 
infected  with vector or one of three Cbl trunca- 
tion mutants (1-480,  1-655,  or 1-840) expressed 
as recombinant vaccinia  viruses.  FceRI was ag- 
gregated (+) or not (-) with DNP-HSA. Cel- 
lular  lysates were directly  electrophoresed  (bot- 
tom)  or were subjected to immunoprecipitation 
with  antibodies  directed  against  the  carboxy 
terminus of Cbl before electrophoresis.  Proteins 
were immunoblotted with antiphosphotyrosine 
(top),  anti-Cbl  (middle),  or anti-HA  antibodies 
(bottom). standing  Cbl  function.  We  have  performed  a  detailed 
analysis  of  FceRI-mediated  tyrosine  phosphorylation  of 
Cbl using a vaccinia virus-mediated expression approach. 
In our studies, overexpression of either Lyn or Syk PTKs 
in RBL-2H3 cells resulted in enhanced Cbl tyrosine phos- 
phorylation. A caveat for these experiments is that one can- 
not be sure that overexpression of a particular PTK and en- 
hanced subsequent tyrosine phosphorylation of a substrate 
indicate that the overexpressed kinase is directly responsible 
for the phosphorylation, as the possibility that one PTK can 
activate another is well known in these systems. Therefore, 
these experiments suggest that either Lyn or Syk, or a PTK 
that is downstream to them, is responsible for Cbl tyrosine 
phosphorylation. However, the complementary reconstitu- 
tion  analysis  in  the  nonhematopoietic  3T3  cell line  pro- 
vides strong evidence that  Syk is able  to  directly tyrosine 
phosphorylate Cbl. The requirement for Src kinase activa- 
tion of Syk was not addressed in these experiments, but in 
view of previous studies, it is possible that endogenous Src 
kinases might have contributed to activation of Syk either 
in the RBL-2H3 or 3T3  cells.  The conclusion that Syk is 
primarily  responsible  for  Cbl  tyrosine  phosphorylation 
needs to be considered in the context of other studies. In B 
cell receptor-mediated signaling,  Tezuka et al.  (45)  dem- 
onstrated  that  Cbl  tyrosine  phosphorylation  occurred  in 
DT40 chicken cells upon IgM cross-linking. This phosphor- 
ylation was  almost fully  abrogated in  Lyn-negative cells, 
but persisted in Syk-negative DT40 cells.  In related exper- 
iments they found that overexpression of Fyn in a T  cell 
hybridoma resulted in enhanced Cbl tyrosine phosphoryla- 
tion.  Blockade  of ZAP-70  activation  either  with  a  non- 
hydrolyzable analogue  of a  TCR-~  ITAM or by overex- 
pression of the tandem SH2 domains of ZAP-70 resulted in 
complete  inhibition  of the  tyrosine phosphorylation  of a 
36-kD substrate, but only partial inhibition of the phosphor- 
ylation of the 120-kD protein likely to be Cbl (46, 47).  It is 
thus likely that Cbl is a substrate for both Src and Syk fam- 
ily PTKs with the relative contribution varying in the dif- 
ferent cellular systems. 
The  function  of Cbl  tyrosine  phosphorylation  has  not 
yet  been  fully  determined.  The  preliminary  truncation 
mapping presented in this study suggests that tyrosine resi- 
dues distal to amino acid 655 are likely to be the major tar- 
get of activated Syk in RBL-2H3 cells. However, the con- 
ditions  of overexpression used  in  these  studies  emphasize 
Syk dependent phosphorylation of Cbl, and therefore leave 
open the possibility that proximal sites of Cbl phosphoryla- 
tion occur and may be mediated by other tyrosine kinases. 
Several recent studies indicate that upon its tyrosine phos- 
phorylation  Cbl  can  be  bound  by  glutathione-S-trans- 
ferase-SH2 fusion proteins in vitro (15,  29). P,  ecently pub- 
lished data suggest that Cbl interaction with Crk proteins is 
mediated by the  Crk SH2  domain  (48).  Inspection of the 
Cbl  sequence  indicates  a  number  of  tyrosine  residues, 
which when tyrosine phosphorylated, are in the appropri- 
ate  context  to  bind  various  SH2  domains.  These  studies 
strongly suggest that tyrosine phosphorylation of Cbl is in- 
timately involved in determining protein-protein interac- 
tions. 
Our  data  further  indicate  that  in  RBL-2H3  cells,  Syk 
and  Cbl exist in a preformed complex. The binding  data 
using Cbl and Syk truncation mutants, suggest that binding 
of Syk to Cbl is mediated through the proline-rich region 
of Cbl.  In addition,  truncation of the Syk protein to leave 
the tandem SH2 domains and a short linker region fails to 
inhibit binding to Cbl.  The ability of this portion  of Syk 
to bind Cbl in the absence of cell activation may be related 
to  a  number  of recent  observations  of phosphotyrosine- 
independent binding of SH2 domains. The SH2 domain of 
Abl binding to Bcr (49),  Src and Fyn SH2 binding to 1Laf 
(50),  Blk SH2 binding to a novel 130-kD protein (51)  and 
Lck SH2 binding to a novel 62-kD protein (52) are poten- 
tial precedents to the observations we report. Alternatively 
the site of interaction with Cbl may prove to be the intra- 
SH2 domain linker region. 
Cbl is now well documented to interact with a number 
of critical tyrosine kinases. Association with Src family ki- 
nases has been shown in T  and B cells (29,  53). However, in 
contrast to our results,  Panchamoorthy et al.  (53)  showed 
that a Cbl-Syk complex was induced by B  cell receptor li- 
gation in Ramos B cells. We do not observe changes in the 
level of protein association in normal ILBL-2H3 cells or re- 
producibly  after  protein  overexpression.  The  differences 
between our results and these other studies may be due to 
differences in such experimental conditions as immunolog- 
ical reagents. 
The  absence  of tyrosine  phosphorylation  of  the  Cbl 
within  the  Cbl-Syk complexes we  observe in  RBL-2H3 
ceils is surprising. In two previous studies reporting interac- 
tions between Cbl and Syk or ZAP-70 kinases, the Cbl co- 
precipitating  with  Syk  or  ZAP-70  was  shown  to  be  ty- 
rosine phosphorylated. The differences between our results 
and these studies may again be due to differences in immu- 
nological  reagents,  or  possibly  because  the  experimental 
conditions  in our studies  emphasize Syk-dependent phos- 
phorylation of Cbl over that mediated by other tyrosine ki- 
nases.  The  data  supporting the  conclusion  that  Syk is  in- 
volved in  this  tyrosine  phosphorylation  and  the  apparent 
direct physical interaction between Syk and Cbl led us to 
expect that that fraction of Cbl binding Syk might be the 
fraction of Cbl subject to phosphorylation.  However, it is 
possible  that  the  complex  might  represent  an  interaction 
that leads to phosphorylation or alternatively, an interaction 
that leads to regulation of Syk activity. 
An  additional  clue  about  the  function  of the  Cbl-Syk 
complex comes from an  experiment in  which  truncation 
mutants  of  Cbl  were  overexpressed  in  RBL-2H3  cells. 
Overexpression of those mutants that were shown to bind 
Syk, 1-655, and 1-840, were able to inhibit tyrosine phos- 
phorylation of endogenous Cbl.  A  truncation mutant that 
fails to bind Syk fails to inhibit tyrosine phosphorylation. At 
this point there are several potential explanations for a re- 
sult that can be viewed as the dominant negative effect of 
mutant overexpression. The mutant forms of Cbl might be 
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necessary  contact  with  the  tyrosine  kinase  molecule  that 
would  normally  phosphorylate  it.  Alternatively,  overex- 
pression  of Syk-binding truncation  mutants  might lead  to 
Syk inhibition.  These are essentially the same explanations 
provided above for the  finding that  Cbl  in  complex with 
Syk is not tyrosine phosphorylated. Both results emphasize 
how tightly  tyrosine  phosphorylation  of Cbl  is  regulated, 
and demonstrate  that a function of Cbl in this system is to 
form complexes with critical tyrosine kinases. Whether Cbl 
in these complexes functions to regulate kinase activity and 
cellular function is currently under study. 
The C. elegans Cbl homologue has been postulated to be a 
negative  regulator  of the  Ras  pathway  (35).  Cbl has been 
shown to act as an adapter molecule in coupling epidermal 
growth  factor  receptor  to  PI-3  kinase  (20,  21).  Another 
study has suggested that Cbl targets ubiquitination and deg- 
radation  of the  CSF-1  receptor  (54).  These functions may 
be mediated by the interactions of SH3-containing proteins 
with the proline-rich domain of Cbl or by SH2-containing 
proteins interacting with tyrosine-phosphorylated Cbl. Our 
observations  indicating  an  interaction  between  the  SH2 
domain/linker regions of Syk and non-tyrosine-phosphor- 
ylated  Cbl  suggests  that  additional  modes  of interaction 
with  Cbl  may exist.  Further  characterization  of this  Cbl- 
Syk complex and  evaluation  of Syk kinase  function when 
complexed with Cbl may lead to more insight into the role 
of this complex protein. 
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